13-25692740-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016529.6(ATP8A2):​c.2212-6433C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 151,946 control chromosomes in the GnomAD database, including 6,067 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6067 hom., cov: 32)

Consequence

ATP8A2
NM_016529.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.929

Publications

1 publications found
Variant links:
Genes affected
ATP8A2 (HGNC:13533): (ATPase phospholipid transporting 8A2) The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
ATP8A2 Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016529.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
NM_016529.6
MANE Select
c.2212-6433C>T
intron
N/ANP_057613.4
ATP8A2
NM_001411005.1
c.2212-6433C>T
intron
N/ANP_001397934.1A0A804HKW9
ATP8A2
NM_001313741.1
c.2092-6433C>T
intron
N/ANP_001300670.1Q9NTI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
ENST00000381655.7
TSL:1 MANE Select
c.2212-6433C>T
intron
N/AENSP00000371070.2Q9NTI2-4
ATP8A2
ENST00000281620.11
TSL:1
n.*1839-6433C>T
intron
N/AENSP00000281620.7F8W9B3
ATP8A2
ENST00000491840.1
TSL:1
n.1083-6433C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.277
AC:
42019
AN:
151826
Hom.:
6063
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.269
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.273
Gnomad ASJ
AF:
0.253
Gnomad EAS
AF:
0.439
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.257
Gnomad OTH
AF:
0.263
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.277
AC:
42056
AN:
151946
Hom.:
6067
Cov.:
32
AF XY:
0.282
AC XY:
20967
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.268
AC:
11118
AN:
41420
American (AMR)
AF:
0.274
AC:
4182
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.253
AC:
876
AN:
3464
East Asian (EAS)
AF:
0.439
AC:
2265
AN:
5154
South Asian (SAS)
AF:
0.463
AC:
2228
AN:
4814
European-Finnish (FIN)
AF:
0.306
AC:
3228
AN:
10562
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.257
AC:
17436
AN:
67950
Other (OTH)
AF:
0.264
AC:
556
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1568
3136
4705
6273
7841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
3037
Bravo
AF:
0.272
Asia WGS
AF:
0.407
AC:
1417
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.056
DANN
Benign
0.83
PhyloP100
-0.93
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7989017; hg19: chr13-26266878; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.